Report Details

Medical Care

Global Fragment-based Drug Discovery Market Insights, Forecast to 2028

ID: XI224659 | Published: Sep 2022 | Pages: 108 | Format: PDF | Industry: Medical Care

Description

ToC

Companies

Speak with Analyst

Fragment-based Drug Discovery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fragment-based Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Fragment-based Drug Discovery Market Segment by Type
Fragment Screening
Fragment Optimization

Fragment-based Drug Discovery Market Segment by Application
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)

Fragment-based Drug Discovery Market by Company
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery

Fragment-based Drug Discovery Market Analysis by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

FAQ

The Fragment-based Drug Discovery market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Fragment-based Drug Discovery market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Fragment-based Drug Discovery report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

  • You should buy this report from Xcellent Insights for a better clarity on market scenarios.
  • The market report has been prepared using a pragmatic approach to suit your needs.
  • We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
  • Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
  • Besides, customization is a value-added service if you decide to opt.

Table of Content
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2017-2028)
2.2 Fragment-based Drug Discovery Growth Trends by Region
2.2.1 Fragment-based Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fragment-based Drug Discovery Historic Market Size by Region (2017-2022)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Region (2023-2028)
2.3 Fragment-based Drug Discovery Market Dynamics
2.3.1 Fragment-based Drug Discovery Industry Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Revenue
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2017-2022)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2017-2022)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2021
3.5 Fragment-based Drug Discovery Key Players Head office and Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2017-2022)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2023-2028)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2017-2022)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2017-2028)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2017-2022)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2023-2028)
6.2.3 North America Fragment-based Drug Discovery Market Share by Type (2017-2028)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2017-2022)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2023-2028)
6.3.3 North America Fragment-based Drug Discovery Market Share by Application (2017-2028)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country (2017-2022)
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2017-2028)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2017-2022)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2023-2028)
7.2.3 Europe Fragment-based Drug Discovery Market Share by Type (2017-2028)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2017-2022)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2023-2028)
7.3.3 Europe Fragment-based Drug Discovery Market Share by Application (2017-2028)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country (2017-2022)
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2017-2028)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type
8.2.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fragment-based Drug Discovery Market Share by Type (2017-2028)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application
8.3.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fragment-based Drug Discovery Market Share by Application (2017-2028)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.4.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2017-2028)
9.2 Latin America Fragment-based Drug Discovery Market Size by Type
9.2.1 Latin America Fragment-based Drug Discovery Market Size by Type (2017-2022)
9.2.2 Latin America Fragment-based Drug Discovery Market Size by Type (2023-2028)
9.2.3 Latin America Fragment-based Drug Discovery Market Share by Type (2017-2028)
9.3 Latin America Fragment-based Drug Discovery Market Size by Application
9.3.1 Latin America Fragment-based Drug Discovery Market Size by Application (2017-2022)
9.3.2 Latin America Fragment-based Drug Discovery Market Size by Application (2023-2028)
9.3.3 Latin America Fragment-based Drug Discovery Market Share by Application (2017-2028)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country
9.4.1 Latin America Fragment-based Drug Discovery Market Size by Country (2017-2022)
9.4.2 Latin America Fragment-based Drug Discovery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2017-2028)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fragment-based Drug Discovery Market Share by Type (2017-2028)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fragment-based Drug Discovery Market Share by Application (2017-2028)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.1.5 Astex Pharmaceuticals Recent Developments
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.2.5 Alveus Pharmaceuticals Recent Developments
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.3.5 Beactica Recent Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.4.5 Charles River Laboratories Recent Developments
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.5.5 Crown Bioscience Recent Developments
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.6.5 Emerald BioStructures Recent Developments
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.7.5 Evotec Recent Developments
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.8.5 Kinetic Discovery Recent Developments
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.9.5 Proteros Fragments Recent Developments
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.10.5 Sprint Bioscience Recent Developments
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.11.5 Structure Based Design Recent Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2017-2022)
11.12.5 Sygnature Discovery Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

Tables and Figures
List of Tables
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Fragment-based Drug Discovery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Fragment-based Drug Discovery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Region (2017-2022)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Region (2023-2028)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Revenue Share by Players (2017-2022)
Table 16. Global Top Fragment-based Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2021)
Table 17. Ranking of Global Top Fragment-based Drug Discovery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 21. Date of Enter into Fragment-based Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2017-2022)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2023-2028)
Table 27. Global Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Share by Application (2017-2022)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Share by Application (2023-2028)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Fragment-based Drug Discovery Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Fragment-based Drug Discovery Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Fragment-based Drug Discovery Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Fragment-based Drug Discovery Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Fragment-based Drug Discovery Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Fragment-based Drug Discovery Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Fragment-based Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Fragment-based Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Fragment-based Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Fragment-based Drug Discovery Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Fragment-based Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Fragment-based Drug Discovery Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Fragment-based Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Fragment-based Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 61. Astex Pharmaceuticals Company Details
Table 62. Astex Pharmaceuticals Business Overview
Table 63. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 64. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 65. Astex Pharmaceuticals Recent Developments
Table 66. Alveus Pharmaceuticals Company Details
Table 67. Alveus Pharmaceuticals Business Overview
Table 68. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 69. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 70. Alveus Pharmaceuticals Recent Developments
Table 71. Beactica Company Details
Table 72. Beactica Business Overview
Table 73. Beactica Fragment-based Drug Discovery Product
Table 74. Beactica Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 75. Beactica Recent Developments
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Fragment-based Drug Discovery Product
Table 79. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 80. Charles River Laboratories Recent Developments
Table 81. Crown Bioscience Company Details
Table 82. Crown Bioscience Business Overview
Table 83. Crown Bioscience Fragment-based Drug Discovery Product
Table 84. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 85. Crown Bioscience Recent Developments
Table 86. Emerald BioStructures Company Details
Table 87. Emerald BioStructures Business Overview
Table 88. Emerald BioStructures Fragment-based Drug Discovery Product
Table 89. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 90. Emerald BioStructures Recent Developments
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec Fragment-based Drug Discovery Product
Table 94. Evotec Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 95. Evotec Recent Developments
Table 96. Kinetic Discovery Company Details
Table 97. Kinetic Discovery Business Overview
Table 98. Kinetic Discovery Fragment-based Drug Discovery Product
Table 99. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 100. Kinetic Discovery Recent Developments
Table 101. Proteros Fragments Company Details
Table 102. Proteros Fragments Business Overview
Table 103. Proteros Fragments Fragment-based Drug Discovery Product
Table 104. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 105. Proteros Fragments Recent Developments
Table 106. Sprint Bioscience Company Details
Table 107. Sprint Bioscience Business Overview
Table 108. Sprint Bioscience Fragment-based Drug Discovery Product
Table 109. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 110. Sprint Bioscience Recent Developments
Table 111. Structure Based Design Company Details
Table 112. Structure Based Design Business Overview
Table 113. Structure Based Design Fragment-based Drug Discovery Product
Table 114. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 115. Structure Based Design Recent Developments
Table 116. Sygnature Discovery Company Details
Table 117. Sygnature Discovery Business Overview
Table 118. Sygnature Discovery Fragment-based Drug Discovery Product
Table 119. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2017-2022) & (US$ Million)
Table 120. Sygnature Discovery Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Share by Type: 2021 VS 2028
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2021 VS 2028
Figure 5. Academic and Research Institutions Case Studies
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Contract Research Organizations (CROs) Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Fragment-based Drug Discovery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Fragment-based Drug Discovery Market Share by Region: 2021 VS 2028
Figure 12. Global Fragment-based Drug Discovery Market Share by Players in 2021
Figure 13. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2021
Figure 15. North America Fragment-based Drug Discovery Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Fragment-based Drug Discovery Market Size Market Share by Type (2017-2028)
Figure 17. North America Fragment-based Drug Discovery Market Size Market Share by Application (2017-2028)
Figure 18. North America Fragment-based Drug Discovery Market Size Share by Country (2017-2028)
Figure 19. United States Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Fragment-based Drug Discovery Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Fragment-based Drug Discovery Market Size Market Share by Type (2017-2028)
Figure 23. Europe Fragment-based Drug Discovery Market Size Market Share by Application (2017-2028)
Figure 24. Europe Fragment-based Drug Discovery Market Size Share by Country (2017-2028)
Figure 25. Germany Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Fragment-based Drug Discovery Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Fragment-based Drug Discovery Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Fragment-based Drug Discovery Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Fragment-based Drug Discovery Market Size Share by Region (2017-2028)
Figure 35. China Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Fragment-based Drug Discovery Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Fragment-based Drug Discovery Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Fragment-based Drug Discovery Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Fragment-based Drug Discovery Market Size Share by Country (2017-2028)
Figure 45. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Fragment-based Drug Discovery Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Fragment-based Drug Discovery Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Fragment-based Drug Discovery Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Fragment-based Drug Discovery Market Size Share by Country (2017-2028)
Figure 51. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Fragment-based Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 55. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 56. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 57. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 58. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 59. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 60. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 61. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 62. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 63. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 64. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 65. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Key Players
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery

Speak With Analyst

Request Free PDF Sample
Pre-Order Enquiry
Check Today's Discount

Why Choose Us

  • Extensive Library of Reports.
  • Identify the clients' needs.
  • Pragmatic Research Approach.
  • Clarity on Market Scenarios.
  • Tailor-Made Solutions.
  • Expert Analysts Team.
  • Competitive and Fair Prices.

Clientele